Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GAPDH


Brief Information

Name:Glyceraldehyde-3-phosphate dehydrogenase liver
Target Synonym:OCAS, P38 Component,GAPD,EC:2.6.99.-,GAPDH,HEL-S-162eP,Epididymis Secretory Sperm Binding Protein Li 162eP,EC,Aging-Associated Gene 9 Protein,G3PD,EC 2.6.99.-,EC 1.2.1,EC:,Glyceraldehyde-3-Phosphate Dehydrogenases,Oct1 Coactivator In S Phase, 38 Kd Component,Glyceraldehyde-3-Phosphate Dehydrogenase,Peptidyl-Cysteine S-Nitrosylase GAPDH
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:0
Lastest Research Phase:Preclinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GAH-H5145 Human Human GAPDH / G3PDH Protein, His Tag
ACRO Quality

Synonym Name



Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is also known as Peptidyl-cysteine S-nitrosylase GAPDH, which is an enzyme that catalyzes the sixth step of glycolysis and thus serves to break down glucose for energy and carbon molecules. GAPDH has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. GAPDH can participate in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Also, GAPDH can modulate the organization and assembly of the cytoskeleton. Furthermore, GAPDH is a component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes.

Clinical and Translational Updates

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message